文献速递妇科

KLK5与宫颈癌的放射抵抗、侵袭和进展相关

KLK5 is associated with the radioresistance, aggression, and progression of cervical cancer.
PubMed 文献 · Gynecol Oncol · 2022-05-18

该研究分析了2014至2016年接受放疗的宫颈癌患者放疗前样本及临床数据,并结合活检组织、体外细胞和裸鼠移植瘤实验,发现KLK5过表达与放疗后不良预后相关,过表达增加放射抵抗,下调则增加放射敏感性,提示KLK5是宫颈癌放射抵抗的新靶点和标志物。

要点

  • KLK5过表达与宫颈癌患者放疗后不良预后相关。
  • 体外和移植瘤实验中KLK5过表达显著增加放射抵抗,下调则增加放射敏感性。
  • KLK5可能是宫颈癌放射抵抗治疗的新靶点和标志物。

核心结论

  • KLK5对宫颈癌放射抵抗至关重要,为宫颈癌放射抵抗的治疗提供了新靶点和标志物。

研究设计与样本

  • 分析2014至2016年接受放疗(未手术或其他抗肿瘤治疗)的宫颈癌患者放疗前样本及相关临床数据。
  • 研究活检组织、体外细胞和裸鼠移植瘤。

主要发现

  • 基因测序和临床数据分析显示KLK5过表达与放疗后不良预后相关。
  • 体外细胞和肿瘤移植实验中,KLK5过表达显著增加放射抵抗。
  • 下调KLK5表达增加放射敏感性。

关键数值与推荐

  • KLK5过表达与放疗后不良预后相关。
  • KLK5过表达显著增加放射抵抗。
  • 下调KLK5表达增加放射敏感性。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The role of kallikrein-related peptidase 5 (KLK5) has been studied in several diseases, including skin and ovarian cancers. However, its role in cervical cancer remains unclear, particularly in regulating the radiation resistance and growth of cervical cancer cells. Radiation resistance of cervical cancer is associated with local recurrence, distant metastasis, and reduced survival. METHODS: We first analyzed radiotherapy-naive samples and relevant clinical data from patients with cervical cancer who received radiotherapy without surgery or other antitumor treatment from 2014 to 2016. Subsequently, biopsied tissues, in vitro cells, and transplanted tumors in nude mice were investigated. RESULTS: Gene sequencing and clinical data analysis showed that KLK5 overexpression was associated with a poor prognosis post-radiotherapy. In in vitro cell and tumor transplantation experiments, KLK5 overexpression significantly increased radiation resistance. However, downregulating KLK5 expression increased radiosensitivity. CONCLUSION: Our results confirm that KLK5 is vital to the radioresistance of cervical cancer, and provide a new target and marker for the treatment of radioresistance in cervical cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Zhou S, Liu S, Tian G, et al. KLK5 is associated with the radioresistance, aggression, and progression of cervical cancer. Gynecol Oncol. 2022. PMID: 35595569. doi:10.1016/j.ygyno.2022.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。